Zobrazeno 1 - 10
of 64
pro vyhledávání: '"James M. McKiernan"'
Autor:
Michael J. Donovan, Ronald F. Tutrone, Johan Skog, Christian Fischer, James M. McKiernan, Vasisht Tadigotla, Mikkel Noerholm, Gordon D. Brown, Erik Margolis, Alan W. Partin, Ballentine Carter, Phillipp Torkler
Publikováno v:
Prostate Cancer and Prostatic Diseases. 25:296-301
Background The ability to discriminate indolent from clinically significant prostate cancer (PC) at the initial biopsy remains a challenge. The ExoDx Prostate (IntelliScore) (EPI) test is a noninvasive liquid biopsy that quantifies three RNA targets
Autor:
Vasisht Tadigotla, Jason Alter, Sonia Kumar, Mikkel Noerholm, James M. McKiernan, Grannum Sant, Michael J. Donovan, Phillipp Torkler, Johan Skog
Publikováno v:
BMC Urology, Vol 20, Iss 1, Pp 1-6 (2020)
BMC Urology
BMC Urology
Background Initial prostate biopsy often fails to identify prostate cancer resulting in patient anxiety, especially when clinical features such as prostate specific antigen (PSA) remain elevated, leading to the need for repeat biopsies. Prostate biom
Autor:
Tom McLain, Ronald F. Tutrone, Johan Skog, James M. McKiernan, Vasisht Tadigotla, Michael J. Donovan, Mikkel Noerholm, Phillipp Torkler
Publikováno v:
Prostate Cancer and Prostatic Diseases
Background The ExoDx Prostate(IntelliScore) (EPI) test is a non-invasive risk assessment tool for detection of high-grade prostate cancer (HGPC) that informs whether to proceed with prostate biopsy. We sought to assess the impact of EPI on the decisi
Autor:
Michael J. Donovan, Alan W. Partin, Gordon A. Brown, Mikkel Noerholm, Ballentine Carter, Johan Karl Olov Skog, Ronald F. Tutrone, James M. McKiernan, Vasisht Tadigotla, Phillipp Torkler, Erik Margolis
BACKGROUND The ability to discriminate indolent from clinically significant prostate cancer (PC) in the initial biopsy setting remains an important health issue. ExoDx Prostate(IntelliScore) (EPI), is a non-invasive exosome based liquid biopsy test t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b0b276ec2bb33670e3852e9b65bdee4
https://doi.org/10.21203/rs.3.rs-131551/v1
https://doi.org/10.21203/rs.3.rs-131551/v1
Autor:
Christopher B. Anderson, Elizabeth Y. Wang, Luis A. Pina, Kevin C. Lee, Jamie S. Pak, James M. McKiernan
Publikováno v:
Urologic oncology. 39(5)
Purpose The American Urological Association guideline for asymptomatic microhematuria recommends in patients with a negative initial workup, repeat workup should be considered for those with persistent/recurrent microhematuria. However, there is litt
Autor:
Joyce E. Johnson, David H. Aggen, Nivedita Chowdhury, Andrea Califano, James M. McKiernan, Xinzheng V. Guo, Marc T. Roth, Scott M. Haake, W. Kimryn Rathmell, Casey Ager, Lukas Vlahos, Charles G. Drake, Brian I. Rini, Eric Jonasch, Kathryn E. Beckermann, Aleksandar Obradovic, Vinson Wang
Publikováno v:
Cell
Clear Cell Renal Carcinoma (ccRCC) is a heterogeneous disease with a variable post-surgical course. To assemble a comprehensive ccRCC tumor microenvironment (TME) atlas, we performed single-cell RNA sequencing (scRNASeq) of hematopoietic and non-hema
Autor:
Christopher B. Anderson, J. Domínguez-Escrig, Robert S. Svatek, Guilherme Godoy, Bernard H. Bochner, Trinity J. Bivalacqua, Michael A. O’Donnell, F Johannes P van Valenberg, Sam S. Chang, Antoine G. van der Heijden, Piyush K. Agarwal, Wassim Kassouf, Colin P.N. Dinney, James M. McKiernan, Jay B. Shah, Eduardo Solsona, Joost L. Boormans, Paramananthan Mariappan, J. Alfred Witjes, Girish S. Kulkarni, Cyrill A. Rentsch, Leonardo L. Monteiro
Publikováno v:
World Journal of Urology, 37(1), 51-60. Springer-Verlag
World Journal of Urology, 37, 1, pp. 51-60
World Journal of Urology, 37, 51-60
World Journal of Urology, 37, 1, pp. 51-60
World Journal of Urology, 37, 51-60
Item does not contain fulltext PURPOSE: To provide a summary of the Third International Consultation on Bladder Cancer recommendations for the management of non-muscle invasive bladder cancer (NMIBC). METHODS: A detailed review of the literature was
Autor:
Michael A. Gorin, Mark Riffon, Akachimere Uzosike, Mohit Gupta, Michael H. Johnson, Hiten D. Patel, Bruce J. Trock, Heather Gausepohl, Ridwan Alam, Zeyad Schwen, Phillip M. Pierorazio, Mohamad E. Allaf, Andrew A. Wagner, James M. McKiernan, Peter Chang
Publikováno v:
Journal of Urology. 199:641-648
Active surveillance is emerging as a safe and effective strategy for the management of small renal masses (4 cm or less). We characterized the growth rate and its pertinence to clinical outcomes in a prospective multi-institutional study of patients
Autor:
Charles G. Drake, Mitchell C. Benson, Christopher B. Anderson, Justin T. Matulay, Guarionex Joel DeCastro, Rashed Ghandour, James M. McKiernan, Michael J Lipsky, Alexa R. Meyer, Dennis J. Robins
Publikováno v:
Urology. 111:116-121
Objective To investigate survival outcomes of patients with muscle-invasive bladder cancer (MIBC) that demonstrate complete clinical response (cT0) to neoadjuvant chemotherapy (NAC) and then reject subsequent radical cystectomy (RC). Methods A retros
Autor:
Sanjay Patel, Gary D. Steinberg, Michael A. O’Donnell, Edouard J. Trabulsi, Siamak Daneshmand, Angela B. Smith, Tracy M. Downs, Matthew J. Resnick, James M. McKiernan, Kamal S. Pohar, Alexander Sankin, Badrinath R. Konety, Jeffrey A. Jones, Trinity J. Bivalacqua, Per-Uno Malmström, Yair Lotan, William C. Huang, Ashish M. Kamat, Michael Woods
Publikováno v:
Nature Reviews. Urology
Blue light cystoscopy (BLC) with hexaminolevulinate (HAL) during transurethral resection of bladder cancer improves detection of non-muscle-invasive bladder cancer (NMIBC) and reduces recurrence rates. Flexible BLC was approved by the FDA in 2018 for